Smita Dandekar

Dr. Smita Dandekar

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2022 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
MCMaxime Caru
Maxime Caru
ALAriane Levesque
Ariane Levesque
PRPooja Rao
Pooja Rao
SDSmita Dandekar
Smita Dandekar
CTChristopher Terry
Christopher Terry
KSKathryn Schmitz
Kathryn Schmitz

31 January 2025 in Journal of Health Psychology
Verified
Journal Article
Closed access
PRPooja Rao
Pooja Rao
JSJoel E Segel
Joel E Segel
KBKristin Bingen
Kristin Bingen
KDKatie Devine
Katie Devine
ASAllison M Scott
Allison M Scott
LSLauren J Van Scoy
Lauren J Van Scoy
Adolescent/young adult cancer survivors (AYACS) are diagnosed with cancer between 15 and 39 years of age. Improving AYACS’ survivorship quality is crucial—including improving social connectedness, a construct describing the quality, structure and function of social relationships. With better understanding of AYACS’ social connectedness, network-based interventions can be developed to foster social health. This study explored how a personal cancer diagnosis impacts AYACS’ social connectedness among 35 AYACS 15–25 years old. Three themes emerged through thematic analysis: (1) AYACS experience substantial heterogeneity related to social support needs; (2) AYACS leverage multiple relationships and resources when seeking support after a personal cancer diagnosis; (3) AYACS’ individual experiences were unique in that some noted positive changes, whereas others noted negative changes in relationships within social networks, specifically with peers. These findings create a foundation to develop social programming, foster peer relationships, and incorporate social science methods to aid intervention development to strengthen AYACS’ social connectedness.

13 September 2025 in Psycho-Oncology
Verified
Journal Article
Open access
PRPooja Rao
Pooja Rao
KDKatie Devine
Katie Devine
KBKristin Bingen
Kristin Bingen
ASAllison M. Scott
Allison M. Scott
LKLaura M. Koehly
Laura M. Koehly
LSLauren J. Van Scoy
Lauren J. Van Scoy
Background: Adolescent/young adult cancer survivors (AYACS), describing people diagnosed with cancer between 15 and 39 years old across the cancer continuum, suffer from poor psychological health. Poor psychological health is associated with difficulty achieving professional goals, financial stress, and poorer health. Aims: The objective of this study was to use a mixed methods approach to understand AYACS’ perspectives on how a personal cancer diagnosis impacts psychological health. Methods: In this convergent mixed methods study, data from 35 AYACS participants were collected consisting of Patient Reported Outcomes Measurement Information System Anxiety and Depression measures, a sociodemographic survey, and semi‐structured interviews. Results: Mixed methods integration revealed the following for AYACS across the cancer continuum: (1) A need for proactive and longitudinal addressal of psychological health; (2) Promotion of social connectedness as a means of coping with illness; (3) A need for innovative and age‐appropriate coping strategies; and (4) Promotion of resilience to help improve psychological health. Conclusions: This study provides direction for intervention development to improve psychological health.

13 February 2024 in Cancer Reports
Verified
Journal Article
Open access
TBTecca Barone
Tecca Barone
SDSmita Dandekar
Smita Dandekar
DMDaniel McKeone
Daniel McKeone
KMKevin Mulieri
Kevin Mulieri
Background: Mercaptopurine is an important component of acute lymphoblastic leukemia (ALL) and lymphoma (LLy) maintenance therapy. The 6‐thioguanine nucleosides (6‐TGN) are believed to be the primary contributor to myelosuppression and immunosuppressive effects, while 6‐methylmercaptopurine (6‐MMPN) is believed to be responsible for several toxicities including hepatotoxicity, pancreatitis, and hypoglycemia. Previous reports suggest the addition of allopurinol may reduce these toxicities.Aims: To assess the use of allopurinol to improve both safety and efficacy of mercaptopurine in pediatric patients with ALL and LLy during maintenance therapy. Secondary objectives included evaluating patient tolerability and skewed metabolism. In addition, we also analyzed mercaptopurine daily dose reduction upon allopurinol initiation.Methods and Results: The primary endpoint was time within goal ANC prior to and after initiation of allopurinol. Secondary endpoints included; improvement in selective toxicities (hepatotoxicity, pancreatitis, and hypoglycemia) and 6‐MMPN to 6‐TGN ratio prior to and after allopurinol initiation. In addition, an exploratory endpoint assessing mercaptopurine daily dose reduction prior to and after allopurinol initiation was included. Sixteen patients met inclusion criteria and 15 (94%) of which were included in this study. Median percent of maintenance days within goal ANC prior to and after initiation of allopurinol was 27.8 (IQR 22.6–44.9) and 41.6 (IQR 20.2–58.2) respectively. All patients experienced selective toxicities; 15 (100%) hepatotoxicity, 1 (7%) pancreatitis, and 3 (20%) hypoglycemia. Improvement of toxicities was seen in 13/15 (87%), 1/1 (100%), and 2/3 (67%) respectively. Average 6‐MMPN:6‐TGN ratio prior to allopurinol initiation was 304:1 and after, allopurinol initiation improved to 15:1, resulting in a 95% reduction. Average mercaptopurine dose prior to and after allopurinol initiation decreased by about 56% (63 to 28 mg/m2/day).Conclusion: Results suggest that the use of allopurinol in pediatric patients with ALL and LLy receiving mercaptopurine during maintenance therapy is both safe and effective.

6 August 2024 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
PRPooja Rao
Pooja Rao
JSJoel E. Segel
Joel E. Segel
KBKristin Bingen
Kristin Bingen
KDKatie Devine
Katie Devine
CRCourtney L. Rumbaugh
Courtney L. Rumbaugh
LSLauren J. Van Scoy
Lauren J. Van Scoy

5 October 2023 in Contemporary Clinical Trials Communications
Verified
Journal Article
Open access
SDSmita Dandekar
Smita Dandekar
MCMaxime Caru
Maxime Caru
KSKathryn H. Schmitz
Kathryn H. Schmitz
Long term survivors of childhood cancer have a high prevalence of chronic pain. Novel, multidisciplinary approaches to manage pain, are needed to allow for a reduction in the use of opioids for pain management. Physical activity is highly effective in managing chronic pain in children and adolescents, however, evidence about the combination of physical activity intervention and pain medications in chronic pain management in childhood cancer survivors is lacking. The aim of this study is to investigate the feasibility, acceptability and preliminary effects of a behavioral physical activity intervention integrated into standard post cancer directed treatment care to mitigate chronic pain in this unique population. This is a single site pilot randomized controlled trial of a 16-week physical activity intervention coupled with standard care. The primary aim is to assess the feasibility and acceptability of the physical activity intervention in childhood cancer survivors with chronic pain. Secondary aims include evaluating the differences in functional and psychosocial outcomes along with self-reported pain scores and cumulative dose of pain medications between the exercise group and standard cancer care group. The physical activity intervention is a home-based program structured to increase patients' physical activity behavior and to favor low intensity bodily movement using aerobic exercise and resistance training. This study will demonstrate that behavioral supportive measures like physical activity may be a novel means to improve cancer related chronic pain in young survivors of childhood cancer and decrease medication usage for pain along with improvement in functional and psychosocial outcomes.